# EU MDR Compliance Checklist for Skin Cancer Detection Project

This checklist tracks regulatory compliance considerations throughout the project. Items are marked as we complete them.

## Phase 0: Foundation & Setup

### Intended Use Definition
- [x] Define primary function: Binary classification (melanoma vs benign)
- [x] Identify input: Dermoscopic images (ISIC 2018 dataset)
- [x] Identify output: Class prediction + uncertainty estimate
- [x] Define target users: Dermatologists (demonstration purposes)

### Risk Management Planning
- [x] Identify primary risks:
  - False negative (missing melanoma) - HIGH RISK
  - False positive (unnecessary biopsies) - MEDIUM RISK
  - Overconfident incorrect predictions - HIGH RISK
- [x] Plan risk mitigation:
  - Uncertainty quantification
  - Calibration
  - Deferral mechanism for uncertain cases

### Dataset Documentation
- [ ] Document data source (Task 0.4.2) ⏳
- [ ] Document preprocessing steps (Task 0.4.3) ⏳
- [ ] Document class distribution (Task 0.4.4) ⏳
- [ ] Document data splits (Phase 1) ⏳

## Phase 1: Baseline Classifier

### Model Architecture
- [ ] Document model choice (EfficientNet-B0)
- [ ] Document model parameters
- [ ] Document pretrained weights source
- [ ] Document training configuration

### Training Process
- [ ] Document training procedure
- [ ] Document hyperparameters
- [ ] Document data augmentation
- [ ] Document class balancing strategy
- [ ] Save training logs

### Initial Evaluation
- [ ] Calculate standard metrics (accuracy, AUROC, sensitivity, specificity)
- [ ] Analyze confusion matrix
- [ ] Identify error patterns
- [ ] Check for bias across subgroups (if metadata available)

### Calibration
- [ ] Measure calibration before temperature scaling (ECE)
- [ ] Apply temperature scaling
- [ ] Measure calibration after temperature scaling
- [ ] Document calibration improvement
- [ ] Create reliability diagrams

## Phase 2: Monte Carlo Dropout (Uncertainty Quantification)

### Epistemic Uncertainty
- [ ] Implement MC Dropout
- [ ] Calculate uncertainty metrics (entropy, mutual information)
- [ ] Analyze uncertainty on correct vs incorrect predictions
- [ ] Optimize number of forward passes
- [ ] Document uncertainty computation

### Uncertainty Validation
- [ ] Verify uncertainty is higher on errors
- [ ] Test on out-of-distribution samples (if available)
- [ ] Analyze uncertainty by confidence level
- [ ] Create uncertainty visualizations

### Combined Approach
- [ ] Combine MC Dropout with temperature scaling
- [ ] Verify calibration is maintained
- [ ] Document combined method benefits

## Phase 3: Deep Ensembles (Alternative Uncertainty)

### Ensemble Implementation
- [ ] Train multiple independent models
- [ ] Implement ensemble aggregation
- [ ] Calculate ensemble uncertainty
- [ ] Compare with MC Dropout uncertainty

### Ensemble Validation
- [ ] Measure ensemble calibration
- [ ] Analyze ensemble diversity
- [ ] Compare computational costs
- [ ] Choose final uncertainty method

## Phase 5: Deferral Mechanism

### Deferral Strategy
- [ ] Define deferral threshold based on uncertainty
- [ ] Simulate deferral on validation set
- [ ] Measure accuracy on retained predictions
- [ ] Measure coverage (% of cases retained)
- [ ] Analyze deferred cases characteristics

### Clinical Usability
- [ ] Create user interface (Gradio)
- [ ] Display prediction + confidence + uncertainty
- [ ] Flag high-uncertainty cases for deferral
- [ ] Provide clear explanations
- [ ] Test interface usability

## Phase 6: Final Evaluation & Documentation

### Comprehensive Testing
- [ ] Final evaluation on held-out test set
- [ ] Measure all performance metrics
- [ ] Measure calibration quality
- [ ] Analyze errors and limitations
- [ ] Document performance by subgroups

### Robustness Testing
- [ ] Test on different image qualities
- [ ] Test on edge cases
- [ ] Test deferral mechanism
- [ ] Document failure modes

### Documentation for Regulatory Review

#### Device Description
- [ ] Detailed description of software
- [ ] Intended use statement
- [ ] Contraindications and warnings
- [ ] Technical specifications
- [ ] Known limitations

#### Risk Management File
- [ ] Risk analysis document
- [ ] Risk mitigation strategies
- [ ] Residual risk assessment
- [ ] Risk-benefit analysis

#### Validation Results
- [ ] Performance metrics report
- [ ] Calibration analysis report
- [ ] Uncertainty quantification report
- [ ] Deferral mechanism evaluation
- [ ] Error analysis report

#### Clinical Evaluation
- [ ] Literature review of similar devices
- [ ] Performance comparison with state-of-the-art
- [ ] Clinical benefits statement
- [ ] Limitations acknowledgment

#### Instructions for Use
- [ ] System requirements
- [ ] Installation instructions
- [ ] Operating instructions
- [ ] Interpretation guide
- [ ] Troubleshooting guide

#### Model Card
- [ ] Model details
- [ ] Intended use
- [ ] Training data description
- [ ] Performance metrics
- [ ] Ethical considerations
- [ ] Caveats and recommendations

## Continuous Requirements

### Version Control
- [x] Git repository initialized
- [ ] Tag releases for each phase
- [ ] Document changes between versions
- [ ] Maintain reproducibility

### Quality Assurance
- [ ] Code review practices
- [ ] Testing procedures
- [ ] Validation procedures
- [ ] Documentation review

### Ethical Considerations
- [ ] Data privacy compliance
- [ ] Bias analysis and mitigation
- [ ] Fairness across demographics
- [ ] Informed consent considerations (if real deployment)

## Post-Project (Beyond Scope)

### For Real Deployment
- [ ] Clinical validation study design
- [ ] Regulatory submission preparation
- [ ] CE marking process
- [ ] Post-market surveillance plan
- [ ] Adverse event reporting system
- [ ] Software updates and maintenance plan

---

## Progress Summary

- **Phase 0**: 4/10 items complete (40%)
- **Phase 1**: 0/15 items complete (0%)
- **Phase 2**: 0/10 items complete (0%)
- **Phase 3**: 0/8 items complete (0%)
- **Phase 5**: 0/10 items complete (0%)
- **Phase 6**: 0/20 items complete (0%)

**Total Progress**: 4/73 items (5.5%)

---

**Last Updated**: 29/01/2026  
**Project Phase**: Phase 0 - Foundation & Setup